Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use

Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use

US Patent 11912711 · Granted Feb 27, 2024

Estimated economic value: $716,893,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025